Federal Supply Schedule 36F79722D0065
Award Date
1/15/22
Last Date to Order
7/14/27
Federal Agency
Veterans Integrated Service Network 12
Awardee
Organon LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract, awarded by the U.S. Department of Veterans Affairs (VA), provides for the procurement of pharmaceutical and hematology-related products. The prime contractor, Orexo US Inc., is a for-profit manufacturer based in Morristown, New Jersey. The contract has a ceiling value of $225,000.00 and a period of performance through January 31, 2026. The scope of the contract encompasses the delivery of drugs, pharmaceuticals, and hematology-related products under...
This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned, small disadvantaged business. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and enables the VA to procure a wide range of pharmaceutical and hematology-related products from the vendor. The $2,225,000 multiple-award contract has a period of performance through June 14, 2026. As a Federal Supply Schedule contract, it...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to Dendreon Pharmaceuticals LLC, a self-certified small disadvantaged business, on June 1, 2020. The contract has a ceiling value of $5,164,550.00 and a period of performance through December 31, 2025. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) schedule and allows the VA to procure a range of pharmaceutical and hematology-related products from the contractor. The scope of...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Ingenus Pharmaceuticals, LLC, provides for the procurement of pharmaceutical and hematology-related products. The $5.2 million, multiple-award contract has a performance period extending through December 14, 2025. As a Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) program, this agreement allows the VA and other federal agencies to order a variety of pharmaceutical...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to H2-Pharma LLC, a for-profit limited liability company, to provide pharmaceuticals and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The FSS contract, part of the Pharmaceuticals and Drugs (FSS-61-IB) schedule, is a multiple award vehicle that allows federal agencies to procure the...
This Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to ADC Therapeutics America, Inc. procures a range of pharmaceutical and hematology-related products. The $540,000.00 contract, which runs from October 1, 2021 through September 30, 2026, is part of the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule and does not utilize any set-asides. As a multiple award contract, the VA can place task orders against this vehicle to acquire the specified drug...
The Federal Supply Schedule (FSS) contract 36F79718D0461 was awarded to Prime Contractor Para Pro LLC, a small disadvantaged business and veteran-owned manufacturer of goods, to provide pharmaceuticals and related hematology products. The contract has a $250,000 ceiling value and a performance period ending on May 31, 2025. This multiple award FSS contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and was awarded by the Department of Veterans Affairs, Veterans...
This Federal Supply Schedule contract, awarded by the U.S. Department of Veterans Affairs (VA), provides the VA with a multiple award vehicle for procuring pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The prime contractor, Reliable 1 Laboratories LLC, is a self-certified small disadvantaged business that was awarded this $1,365,780.00 contract with a period of performance through July 14, 2026. The contract aims to supply the VA with a wide range of pharmaceutical and...